This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Pfizer Corporation. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Innovations by Lulin Wei in Pharmaceutical Development
Introduction
Lulin Wei is an accomplished inventor and researcher based in Salem, Connecticut. With a keen focus on pharmaceutical innovations, he has contributed to the field through his work at Pfizer Corporation. His inventive spirit and dedication have led to significant advancements in drug development.
Latest Patents
Lulin Wei holds one patent titled "Process for preparing 4′-substituted-9-deoxo-9a-aza-9a-homoerythromycin A derivatives." This patent reflects his expertise in creating novel compounds that can enhance therapeutic options within the pharmaceutical industry.
Career Highlights
At Pfizer Corporation, Lulin Wei has played a pivotal role in the research and development of new medications. His work not only contributes to the company's portfolio but also aims to address critical health challenges faced by patients worldwide.
Collaborations
Lulin has had the opportunity to collaborate with notable colleagues, including Constantine Sklavounos and John L. Tucker. Their combined expertise fosters a dynamic environment for innovation and breakthroughs in pharmaceutical sciences.
Conclusion
Lulin Wei’s contributions to the field of pharmaceuticals through his patent and collaborative efforts demonstrate his commitment to advancing healthcare solutions. His work at Pfizer Corporation showcases the impact of dedicated inventors in bringing innovative therapies to the market.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile